High Grade Serous Ovarian Carcinoma Hgsoc clinical trials

Explore recruiting high grade serous ovarian carcinoma hgsoc clinical trials.

Recruiting high grade serous ovarian carcinoma hgsoc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Grade Serous Ovarian Carcinoma Hgsoc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors

France, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

High Grade Serous Ovarian Carcinoma Hgsoc trials by city

High Grade Serous Ovarian Carcinoma Hgsoc clinical trials

Recruiting high grade serous ovarian carcinoma hgsoc studies right now

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

Also recruiting in Europe

Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors

High Grade Serous Ovarian Carcinoma Hgsoc trials by city

Other conditions